NCT01362283

Brief Summary

The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,109

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2010

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2011

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 30, 2011

Completed
Last Updated

December 1, 2016

Status Verified

November 1, 2016

Enrollment Period

5 months

First QC Date

May 5, 2011

Last Update Submit

November 30, 2016

Conditions

Hypertension

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with cardiovascular disease high risk factors

    Between patients with essential hypertension

    6years, average duration of hypertension

Secondary Outcomes (3)

  • Proportion of patients with Cardiovascular disease risk factors

    6years, average duration of hypertension

  • Proportion of patients with Cardiovascular disease

    6years, average duration of hypertension

  • Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks

    6years, average duration of hypertension

Study Arms (1)

Hypertension

Subject who meet eligible criteria

Other: Blood Sampling

Interventions

Blood SamplingOTHER

Blood sampling for Fasting Plasma Glucose, Hemoglobin A1C, Cholesterols, Blood Urea Nitrogen, Creatinine

Also known as: Blood sampling for cardiovascular disease risk
Hypertension

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Korea, Diagnosed hypertensive patient

You may qualify if:

  • Essential hypertensive patient no less than 18 yeas old
  • Patient who gave informed consent form

You may not qualify if:

  • Patient was diagnosed as secondary hypertension
  • Patient who have white-coat hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hypertension

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • GSK Clinical Trials

    GlaxoSmithKline

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2011

First Posted

May 30, 2011

Study Start

August 1, 2010

Primary Completion

January 1, 2011

Study Completion

January 1, 2011

Last Updated

December 1, 2016

Record last verified: 2016-11